Health
Three common medications lower risk and mortality for lung cancer – Medical Xpress
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
All three medications are commonapproximately 35 million people take a statin to control cholesterol; more than 120 million people take metformin to control diabetes; and between 6 and 10 million people take aspirin daily.
The aim of this study was to investigate the associations of aspirin, metformin, and st…
-
Noosa News16 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business19 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
Business18 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General14 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse